Transfection of L929 cells with complement subcomponent C1q B-chain antisense cDNA inhibits tumor necrosis factor-alpha binding to mediate cytotoxicity and nitric oxide generation

Cell Immunol. 1996 Feb 1;167(2):293-301. doi: 10.1006/cimm.1996.0038.

Abstract

The role of complement subcomponent C1q in the modulation of TNF-alpha binding to L929 cells to mediate cytotoxicity and nitric oxide (NO) generation was investigated. Transfection of L929 with murine C1q B-chain antisense plasmid cDNA rendered them markedly less susceptible to TNF-mediated cytotoxicity coincident with a decreased capacity for TNF-alpha binding and expression of cell surface C1q protein. The inhibitory effects of L929 transfection with C1q B-chain antisense were transiently expressed at 24 hr post-transfection with full recovery of cellular functions by 72 hr. Transfected L929 cells were fully reconstituted in their TNF-alpha binding and in their cytotoxic response following exposure to soluble C1q which was bound to their cell surface. Transfection with C1q B-chain antisense also significantly inhibited NO generation by L929 cells in response to stimulation by TNF-alpha, IFN-alpha/beta, and LPS. Taken together, these results indicate that endogenously synthesized C1q is prerequisite for binding of TNF-alpha to L929 cells to mediate cytotoxicity and NO generation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Complement C1q / physiology*
  • Cytotoxicity, Immunologic*
  • DNA, Antisense
  • DNA, Complementary / genetics
  • L Cells
  • Macrophages / physiology
  • Mice
  • Nitric Oxide / biosynthesis*
  • Signal Transduction
  • Transfection
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • DNA, Antisense
  • DNA, Complementary
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • Complement C1q